Literature DB >> 19074866

Eph receptors and Ephrins in cancer: common themes and controversies.

Jin Chen1, Guanglei Zhuang, Leslie Frieden, Waldemar Debinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19074866      PMCID： PMC2605675          DOI： 10.1158/0008-5472.CAN-08-3010

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  30 in total

1.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Eph receptor and mTOR pathway crosstalk: implications for cancer.

Authors:  Mustafa Sahin
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

3.  Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.

Authors:  Lei Teng; Mitsutoshi Nakada; Natsuki Furuyama; Hemragul Sabit; Takuya Furuta; Yutaka Hayashi; Takahisa Takino; Yu Dong; Hiroshi Sato; Yoshimichi Sai; Ken-Ichi Miyamoto; Michael E Berens; Shi-Guang Zhao; Jun-Ichiro Hamada
Journal:  Neuro Oncol       Date:  2013-10-11       Impact factor: 12.300

4.  Structure-activity relationship analysis of peptides targeting the EphA2 receptor.

Authors:  Sayantan Mitra; Srinivas Duggineni; Mitchell Koolpe; Xuejun Zhu; Ziwei Huang; Elena B Pasquale
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

5.  Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.

Authors:  Shuigen Zhou; Longxin Wang; Guimei Li; Zhengyu Zhang; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

6.  Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases.

Authors:  Jing Dong; Hongtao Zhao; Ting Zhou; Dimitrios Spiliotopoulos; Chitra Rajendran; Xiao-Dan Li; Danzhi Huang; Amedeo Caflisch
Journal:  ACS Med Chem Lett       Date:  2014-09-29       Impact factor: 4.345

7.  The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Authors:  Bénédicte Foveau; Gaylor Boulay; Sébastien Pinte; Capucine Van Rechem; Brian R Rood; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

Review 8.  Molecular ultrasound assessment of tumor angiogenesis.

Authors:  Nirupama Deshpande; Marybeth A Pysz; Jürgen K Willmann
Journal:  Angiogenesis       Date:  2010-06-12       Impact factor: 9.596

9.  Effects of cancer-associated EPHA3 mutations on lung cancer.

Authors:  Guanglei Zhuang; Wenqiang Song; Katherine Amato; Yoonha Hwang; Keunwook Lee; Mark Boothby; Fei Ye; Yan Guo; Yu Shyr; Luping Lin; David P Carbone; Dana M Brantley-Sieders; Jin Chen
Journal:  J Natl Cancer Inst       Date:  2012-07-24       Impact factor: 13.506

10.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.